Bariatric surgery associated with Lower risk of haematological cancer among women: Lancet Dr. Kamal Kant Kohli27 Sept 2023 8:00 PM ISTPrevious studies have shown that overweight and obesity are risk factors for several types of cancer. It is also known that obese women have a higher...
Acute appendicitis among young patients linked to right-side colon cancer Aditi27 Sept 2023 8:45 AM ISTAppendicitis, the most common digestive surgical emergency, has a growing incidence worldwide, with male predilection between 10 and 30 years at the...
Breast cancers detected on MRI screens are most often invasive, study finds Medha Baranwal26 Sept 2023 8:00 PM ISTUSA: A recent study published in Clinical Breast Cancer has found that MRI screen-detected breast cancers are most often invasive. Cancers detected by...
Stem cell therapy can safely slow progression of relapsing-remitting MS Dr. Kamal Kant Kohli26 Sept 2023 5:00 AM ISTStem cells harvested from a person's own bone marrow or blood, can safely slow progression of the most common form of the autoimmune disease, multiple...
Biomarker directed thromboprophylaxis reduces risk of thromboembolism in Cancer patients: JAMA Jacinthlyn Sylvia23 Sept 2023 11:00 AM ISTThromboprophylaxis, the prevention of blood clots, is a critical concern for individuals undergoing systemic anticancer therapies. Recent research...
Breast Cancer Treatments Linked to Increased Risk of Type 2 Diabetes Jacinthlyn Sylvia23 Sept 2023 11:00 AM ISTA new study published in Breast Cancer Research and Treatment raised concerns about the potential link between breast cancer and an increased risk of...
Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis Dr. Kamal Kant Kohli20 Sept 2023 8:00 PM ISTCholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer. Statin treatment was...
Momelotinib receives FDA approval for patients of myelofibrosis with anaemia Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUSA: JAK inhibitor momelotinib (Ojjaara) has received approval from the US Food and Drug Administration (FDA) as the first therapy specifically for...
FDA approves JAK inhibitor Momelotinib for Myelofibrosis in Anemic adults Isra Zaman19 Sept 2023 9:30 AM ISTThe US Food and Drug Administration (FDA) has approved momelotinib for the treatment of intermediate or high-risk myelofibrosis, including primary...
Gastro-oesophageal reflux disease may not increase risk of esophageal cancer Dr. Kamal Kant Kohli18 Sept 2023 8:00 PM ISTReflux disease manifests as acid regurgitation and heartburn and is a known risk factor for oesophageal cancer. However, a new study published in The...
FDA approves new and updated indications for temozolomide Isra Zaman18 Sept 2023 10:00 AM ISTThe Food and Drug Administration (FDA) recently approved updated labeling for temozolomide under an initiative aimed at updating labeling information...
Merkel Cell Carcinoma patients have high risk of subsequent cancers Isra Zaman18 Sept 2023 10:00 AM ISTA recent cohort study published in JAMA Dermatology found that patients with Merkel Cell Carcinoma or MCC had an increased risk of subsequently...
